Nurix Therapeutics Inc (NRIX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 11/30
| 11-2024 | 08-2024 | 05-2024 | 02-2024 | 11-2023 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 109,997 | 99,044 | 116,790 | 49,813 | 54,627 |
| Marketable Securities | 499,586 | 349,008 | 326,349 | 194,180 | 233,281 |
| TOTAL | $619,387 | $456,043 | $450,217 | $250,969 | $295,503 |
| Non-Current Assets | |||||
| PPE Net | 17,757 | 17,069 | 18,557 | 17,871 | 16,808 |
| Investments And Advances | 0 | 9,472 | 9,380 | 10,292 | 7,421 |
| Other Non-Current Assets | 32,199 | 31,016 | 32,877 | 33,542 | 35,866 |
| TOTAL | $49,956 | $57,557 | $60,814 | $61,705 | $60,095 |
| Total Assets | $669,343 | $513,600 | $511,031 | $312,674 | $355,598 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 11,482 | 3,918 | 2,813 | 5,918 | 6,401 |
| Accrued Expenses | 37,994 | 27,828 | 23,263 | 28,318 | 24,970 |
| TOTAL | $95,854 | $86,296 | $80,779 | $87,623 | $86,958 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 38,364 | 47,997 | 46,769 | 46,077 | 48,098 |
| Other Non-Current Liabilities | 20,289 | 20,590 | 20,885 | 21,846 | 23,125 |
| TOTAL | $46,496 | $50,448 | $59,559 | $56,303 | $68,147 |
| Total Liabilities | $142,350 | $136,744 | $140,338 | $143,926 | $155,105 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 75,887 | 70,836 | 64,412 | 49,151 | 48,894 |
| Common Shares | 76 | 67 | 64 | 49 | 49 |
| Retained earnings | -738,769 | -680,220 | -631,264 | -586,718 | -545,200 |
| Other shareholders' equity | 150 | 344 | -135 | -350 | -655 |
| TOTAL | $526,993 | $376,856 | $370,693 | $168,748 | $200,493 |
| Total Liabilities And Equity | $669,343 | $513,600 | $511,031 | $312,674 | $355,598 |